A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease
Study Identifier
M14-327
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 2
Sex
Female & Male
Age
18 - 75 Years
Protocol Summary
This is a open-label extension (OLE) study designed to evaluate the long-term efficacy, safety, and tolerability of Upadacitinib (ABT-494).
Study Locations
Location
Status
Location
UC San Diego Health System /ID# 150041
La Jolla, California, United States, 92037
Status
Not applicable
Location
Univ California, San Francisco /ID# 149987
San Francisco, California, United States, 94143-2204
Status
Not applicable
Location
Duplicate_University of Florida - Archer /ID# 150033
Gainesville, Florida, United States, 32610
Status
Not applicable
Location
The Ctr for Gastro Disorders /ID# 150012
Hollywood, Florida, United States, 33021
Status
Not applicable
Location
Nature Coast Clinical Research - Inverness /ID# 149975
Inverness, Florida, United States, 34452-4717
Status
Not applicable
Location
Gastroenterology Associates of Central Georgia, LLC /ID# 149870
Macon, Georgia, United States, 31201
Status
Not applicable
Showing {first} - {last} of {total} Results